Development of a prediction score for in-hospital mortality in COVID-19 patients with acute kidney injury: a machine learning approach.

Journal: Scientific reports
Published Date:

Abstract

Acute kidney injury (AKI) is frequently associated with COVID-19 and it is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting in-hospital mortality in COVID-19 patients with AKI (AKI-COV score). This was a cross-sectional multicentre prospective cohort study in the Latin America AKI COVID-19 Registry. A total of 870 COVID-19 patients with AKI defined according to the KDIGO were included between 1 May 2020 and 31 December 2020. We evaluated four categories of predictor variables that were available at the time of the diagnosis of AKI: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) characteristics and causes of AKI. We used a machine learning approach to fit models in the training set using tenfold cross-validation and validated the accuracy using the area under the receiver operating characteristic curve (AUC-ROC). The coefficients of the best model (Elastic Net) were used to build the predictive AKI-COV score. The AKI-COV score had an AUC-ROC of 0.823 (95% CI 0.761-0.885) in the validation cohort. The use of the AKI-COV score may assist healthcare workers in identifying hospitalized COVID-19 patients with AKI that may require more intensive monitoring and can be used for resource allocation.

Authors

  • Daniela Ponce
    Department of Internal Medicine, Botucatu Medical School, University of São Paulo State-UNESP, Avenida Professor Mario Rubens Montenegro, Botucatu, São Paulo, 18618-687, Brazil. daniela.ponce@unesp.br.
  • Luís Gustavo Modelli de Andrade
    Department of Internal Medicine, Botucatu Medical School, University of São Paulo State-UNESP, Avenida Professor Mario Rubens Montenegro, Botucatu, São Paulo, 18618-687, Brazil.
  • Rolando Claure-Del Granado
    Division of Nephrology, Hospital Obrero No. 2 - CNS, Universidad Mayor de San Simon, School of Medicine, Cochabamba, Bolivia.
  • Alejandro Ferreiro-Fuentes
    Division of Nephrology, School of Medicine, Universidad de La República, Montevideo, Uruguay.
  • Raul Lombardi
    Division of Nephrology, School of Medicine, Universidad de La República, Montevideo, Uruguay.